Future Planet Capital Portfolio Companies

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

Ultromics develops AI-driven cardiology solutions to assist in cardiovascular disease diagnosis through echocardiography.

Nourished provides a customized nutrition product that uses patented 3D printing technology to create bespoke gummy vitamins on demand.

Maeving is a new ear of beautiful, classically-styled electric motorcycles.

52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.

Globally-unique platform technology for the development of single-molecule crop biostimulants.

Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.

Quantum technology spin-out from the University of Oxford

Linear Diagnostics Limited is a diagnostics company based on a novel technology

Zentraxa has specialise in the design, production and testing of complex novel peptides.

Q5D provides the robotic tools, software and services needed to automate the manufacture of wiring harnesses

Inicio AI is a SaaS platform that builds the conversational AI driven tool that helps in income and expenditure assessment.

When in Rome plays a leading role in decarbonising the wine industry, selling Italian craft wines in eco-friendly alt packaging

Alloyed develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components.

Presymptom Health is a pioneering Medtech company that creates innovative tests to diagnose illnesses earlier to help save lives.

4.01 is a company that specializes in eliminating CO2 from the atmosphere by mineralizing it in peridotite.

Vitarka Therapeutics develops medical technology and solutions for various types of cancer.

AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.

Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.

iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

Smart Green Shipping develops technical, commercially viable, digitally enabled wind-powered solutions.

Lineat uses reclaimed carbon fiber to produce a fiber aligned tape that can be used to manufacture new composite components.

Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.